REFERENCES
- Frost BM, Forestier E, Gustafsson G, Translocation t(1;19) is related to low cellular drug resistance in childhood acute lymphoblastic leukemia. Leukemia. 2005;19:165–169.
- Rubnitz JE, Pui CH. Recent advances in the treatment and understanding of childhood acute lymphoblastic leukaemia. Cancer Treat Rev. 2003;29:31–44.
- Andersen MK, Autio K, Barbany G, Paediatric B-cell precursor acute lymphoblastic leukaemia with t(1;19)(q23;p13): clinical and cytogenetic characteristics of 47 cases from the Nordic countries treated according to NOPHO protocols. Br J Haematol. 2011;155(2):235–243.
- Kager L, Lion T, Attarbaschi A, Incidence and outcome of TCF3-PBX1-positive acute lymphoblastic leukemia in Austarian children. Haematologica. 2007;92(11):1561–1564.
- Jeha S, Pei D, Raimondi SC, Increased risk of CNS relapse in pre-B cell leukemia with the t (1;19)/ TCF3- PBX1. Leukemia. 2009;23:1406–1409.
- Forestier E, Johansson B, Borgstrom G, Immnophenotypic and cytogenetic findings in a population based series of 787 childhood acute lymphoblastic leukemia from Nordic countries. Eur J Hematol. 2000;64:194–200.
- Harris NL, Jaffe ES, Diebold J, The World Health Organization classification of neoplasms of the hematopietic and lymphoid tissues. Hematology J. 2000;1:55.
- Matloub Y, Angiolillo A, Bostrom B, Double delayed intensification is equivalent to single DI(SDI) in children with National Cancer Institute(NCI) standard-risk acute lymphoblastic leukemia (SR-ALL) treated on Children's Cancer Group (CCG)Clinical Trial 1991 (CCG 1991). (Abstracts) Blood. 2006;108(11):A-146.
- Seibel NL, Steinherz PG, Sather HN, Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood. 2008;111(5):2548–2555.
- Mahmoud HH, Rivera GK, Hancock ML, Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia. N Engl J Med. 1993;329:314–319
- Vega F, Orduz R, Medeiros LJ. Chromosomal translocation and their role in pathogenesis of non Hodgkins lymphoma. Pathology. 2002; 34(5):397–409.
- Paulsson K, Jonson T, Ora I, Characterisation of genomic translocation breakpoints and identification of an alternative TCF3/PBX1 fusion transcript in t(1;19)(q23;p13)-positive acute lymphoblastic leukemias. Br J Haematol. 2007;138(3):196–201.
- Uckun PM, Sensel MG, Sather HN, Clinical significance of t(1;19) in childhood acute lymphoblast leukemia in the context of contemporary therapies: a report from the Children's Cancer Group. J Clin Oncol. 1998;16:527–535.
- Pui CH, Pei D, Sandlund JT, Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia. Leukemia. 2010;24:371–382.
- Moorman AV, Chilton L, Wilkinson J, A population-based cytogenetic study of adults with acute lymphoblastic leukemia. Blood. 2010;115:206.
- Baruchel A, Chevret S, Auvrignon A, A plateau after 30 months of follow-up in B-lineage childhood acute lymphoblastic leukemia with t(1;19)(q23;p13)/E2A-PBX1. Blood. 2005;1441(106):416a.